Showing 421 - 440 results of 10,572 for search '"tumor"', query time: 0.08s Refine Results
  1. 421
  2. 422

    Adrenal Rest Tumor of the Liver Preoperatively Diagnosed as Hepatocellular Carcinoma by Megumu Enjoji, Katsuya Sanada, Ryota Seki, Takashi Ito, Masato Maeda

    Published 2017-01-01
    “…Hepatic adrenal rest tumors are rare and show similar findings to hepatocellular carcinoma (HCC). …”
    Get full text
    Article
  3. 423

    Treatment Choices for Tenosynovial Giant Cell Tumor: Surgery or Observation? by Hairong XU, Jing CHEN, Xiaohui NIU

    Published 2025-01-01
    Subjects: “…tenosynovial giant cell tumor…”
    Get full text
    Article
  4. 424

    Characterization of tumor evolution by functional clonality and phylogenetics in hepatocellular carcinoma by Zeynep Kacar, Eric Slud, Doron Levy, Julián Candia, Anuradha Budhu, Marshonna Forgues, Xiaolin Wu, Arati Raziuddin, Bao Tran, Jyoti Shetty, Yotsawat Pomyen, Jittiporn Chaisaingmongkol, Siritida Rabibhadana, Benjarath Pupacdi, Vajarabhongsa Bhudhisawasdi, Nirush Lertprasertsuke, Chirayu Auewarakul, Suleeporn Sangrajrang, Chulabhorn Mahidol, Mathuros Ruchirawat, Xin Wei Wang

    Published 2024-03-01
    “…Abstract Hepatocellular carcinoma (HCC) is a molecularly heterogeneous solid malignancy, and its fitness may be shaped by how its tumor cells evolve. However, ability to monitor tumor cell evolution is hampered by the presence of numerous passenger mutations that do not provide any biological consequences. …”
    Get full text
    Article
  5. 425
  6. 426

    Phosphatidylserine-Targeted Nanotheranostics for Brain Tumor Imaging and Therapeutic Potential by Lulu Wang MD, PhD, Amyn A. Habib MD, Akiva Mintz MD, PhD, King C. Li MD, Dawen Zhao MD, PhD

    Published 2017-05-01
    “…However, this PS asymmetry is found disruptive in many tumor vascular endothelial cells. We discuss the underlying mechanisms for PS asymmetry maintenance in normal cells and its loss in tumor cells. …”
    Get full text
    Article
  7. 427

    Population pharmacokinetics of iruplinalkib in healthy volunteers and patients with solid tumors by Guihong Yang, Yimei Wang, Huimin Zhao, Ziyi Jiang, Shansong Zheng, Mingjing Ge, Meimei Si, Xiaoyan Kang

    Published 2025-01-01
    “…Plasma concentration–time data were collected from 392 participants (16 healthy volunteers and 372 patients with solid tumors) who received single or multiple doses of iruplinalkib in four trials. …”
    Get full text
    Article
  8. 428

    Harnessing nanoparticles for reshaping tumor immune microenvironment of hepatocellular carcinoma by JinSong Li, GuanBo Zhang, Gang Li, Jie Zhang, Zhi Yang, Lin Yang, ShiJie Jiang, JiaXing Wang

    Published 2025-02-01
    “…However, acquired resistance and the tumor immunosuppressive microenvironment (TIME) significantly hinder its clinical application. …”
    Get full text
    Article
  9. 429

    The Role and Therapeutic Potential of Endothelial Progenitor Cells in Tumor Neovascularization by Branislava Janic, Ali S. Arbab

    Published 2010-01-01
    “…Although the cellular and molecular mechanisms of tumor growth and metastasis are not completely understood, it is established that formation and growth of new blood vessels is a conditio sine qua non for tumor survival, growth, and expansion. …”
    Get full text
    Article
  10. 430

    Endometrioid Paraovarian Borderline Cystic Tumor in an Infant with Proteus Syndrome by Liliana Vasquez, Mariela Tello, Ivan Maza, Monica Oscanoa, Milagros Dueñas, Haydee Castro, Alan Latorre

    Published 2015-01-01
    “…Ovarian and paraovarian neoplasms are uncommon in children, mainly originating from germ cell tumors and, least frequently, epithelial tumors. There is an association between genital tract tumors and Proteus syndrome, a rare, sporadic, and progressive entity, characterized by a postnatal overgrowth in several tissues caused by a mosaic mutation in the AKT1 gene. …”
    Get full text
    Article
  11. 431

    Nongenetic evolution of the tumor: from challenges to new therapeutic opportunities by Elisa Oricchio

    Published 2025-01-01
    “…Indeed, several cell‐intrinsic and cell‐extrinsic mechanisms contribute to tumor evolution. In this viewpoint, I focus on how chromatin, epigenetic, and transcriptional changes contribute to tumor evolution, allowing cancer cells to transition to different cell states and bypass response to therapies. …”
    Get full text
    Article
  12. 432

    Advances in sodium-glucose transporter protein 2 inhibitors and tumors by Jiaqi Wang, Wenyong Yang

    Published 2025-02-01
    “…Tumor is a major challenge to global health and has received extensive attention worldwide due to its high degree of malignancy and poor prognosis. …”
    Get full text
    Article
  13. 433
  14. 434

    Imaging of CD47 Expression in Xenograft and Allograft Tumor Models by Alexander Zheleznyak, Oluwatayo F. Ikotun, Julie Dimitry, William A. Frazier, Suzanne E. Lapi

    Published 2013-11-01
    “…CD47 has been shown to be overexpressed by various tumor types as a means of escaping the antitumor immune response. …”
    Get full text
    Article
  15. 435

    Electrical impedance-based tissue classification for bladder tumor differentiation by Carina Veil, Franziska Krauß, Bastian Amend, Falko Fend, Oliver Sawodny

    Published 2025-01-01
    “…With bladder cancer, an important issue is tumor recurrence because of failure to remove the entire tumor. …”
    Get full text
    Article
  16. 436
  17. 437
  18. 438
  19. 439
  20. 440

    Conventional Chemotherapy and Inflammation: What Is the Role of the Inflammasome in the Tumor Microenvironment? by Chiara Colarusso, Michela Terlizzi, Simone Di Caprio, Anna Falanga, Emmanuel D’Andria, Roberta d’Emmanuele di Villa Bianca, Rosalinda Sorrentino

    Published 2025-01-01
    “…While the inflammatory process can facilitate tumor establishment and progression, on the other hand, current clinical approaches aim to boost the immune system against the tumor mass. …”
    Get full text
    Article